2017 CTAC TREATMENT ACCESS CONFERENCE

Join the Canadian Treatment Action Council (CTAC) in Toronto to identify strategies to overcome treatment access barriers and promote health equity.

CONFERENCE LOCATION


Novotel North York

3 Park Home Avenue

North York, Ontario M2N 6L3

Canada

http://www.accorhotels.com/gb/hotel-0910-novotel-toronto-north-york/index.shtml


REGISTER HERE



Select Tickets


We're sorry, but there are no tickets available now.

View Event Policies & FAQs

CONFERENCE SCHEDULE


Wednesday, February 1, 2017

2:00 PM - 5:00 PM

Pre-Conference Sessions: Wednesday, February 1

ANCILLARY SESSION #1: TxMAP Workshop (max 20 per session)

Workshop Overview: The workshop will provide hands-on computer-based training for the Treatment Map (TxMAP) – a comprehensive online tool that is now available on the CTAC website. The objective of the training will be to increase the literacy of community members and service providers to interactively access information on:

  • Canada’s 13 publicly funded provincial and territorial HIV and hepatitis C treatments
  • Treatments covered under the five federal public drug plans
  • Treatments currently under development
  • Cross-jurisdictional and relocation-related legislation and processes linked to treatment access
  • Available individual and community resources to ease transition when moving between jurisdictions

2:00 PM - 5:00 PM

ANCILLARY SESSION #2:  Patient Group Input Workshop (max 20 per session)

Workshop Overview:  The workshop will provide informative strategies to engage patients and fulfill the Canadian Agency for Drugs and Technologies in Health (CADTH) patient input template requirements; provide suggestions for innovative approaches to improving patient input solicitation and reporting; and discuss how to systematize patient group engagement and create a support network for patient groups to assist each other in managing patient input: 

  • Canadian Drug Expert Committee (CDEC) member, Dr. Ahmed Bayoumi, will reflect on how CDEC assesses patient input and where it could be strengthened.
  • Patient group representatives, Gail Attara and Adam Cook, will share their procedures in developing patient input.
  • Representatives from the pan-Canadian Pharmaceutical Alliance (pCPA) and Ontario’s Exceptional Access Program will reflect on how the pCPA and Ontario assesses patient input and where it could be strengthened. 
  • Break-out discussions will allow participants to select and explore key themes as their interests and learning needs direct.

2:00 PM - 5:00 PM

ANCILLARY SESSION #3:  Community Mobalization Workshop (max 20 per session)

Workshop Overview:  The workshop will showcase innovative examples of community mobilization in urban and rural settings; and discuss strategies, challenges and opportunities:

  • Christian Hui will share his experience in the formation and mobilization of CANADIAN POSITIVE PEOPLE NETWORK (CPPN) / RESEAU CANADIEN DES PERSONNES SEROPOSITIVES (RCPS): An independent network for and by Persons Living with HIV/AIDS and HIV co-infections in Canada.
  • Sipiwe Mapfumo, African Communities Project Coordinator, HIV Community Link, Calgary will share her story on community engagement for hard to reach clients in rural as well as urban settings.
  • Zoë Dodd, harm reduction and hep C worker, and antipoverty + social justice activist working at The Toronto Community Hepatitis C Program (TCHCP), will be reflecting on the work she has been carrying out with innovative, client-centred, collaborative care model of hepatitis C treatment, support and education for people who have difficulty accessing hospital-based hepatitis C care, and also share why this program has been so successful.

6:00 PM - 10:00 PM

Welcome Dinner

Keynote Address:  Louise Binder
Guest Speaker:  John McCullagh on The Canadian Consensus Statement: An ethical framework for HIV treatment and care

Thursday, February 2, 2017

8:00 AM - 5:15 PM

Conference Day One Agenda:  HIV
 
Time Session
8:00-9:00 Breakfast and Registration
9:00-9:10 Welcome from CTAC ED & Chair
9:10-9:15 Territorial Acknowledgement and Prayer
9:15-12:15 Session One:  Barriers to Access
9: 20-9:30 Regulatory Overview
9:30-10:15 PrEP Access:  Throughout Canada and a BC Example
10:15-11:00 Creating PrEP Access in Transgender Communities
11:00-11:10 Break
11:10-11:40 Access from an Sex Worker Perspective
11:40-12:00 Access from an Indigenous/Prisoner Perspective
12:00-12:15 Q&A
12:15-1:15 Lunch
1:15-4:15 Session Two:  The Future of HIV  Treatment
1:20:2:15 HIV and Aging
2:15-2:45 Future of PrEP
2:45-2:55 Break
2:55-3:15 New Vaccines and Technologies
3:15-3:50 PHA’s & the Continuum of Care
3:50-4:05 Q&A
4:05-4:15 Break
4:15-5:00 Debate:  PrEP Implementation and Challenges
5:00-5:15 Wrap-up & Day One Evaluations

Friday, February 3, 2017

8:00 AM - 3:30 PM

Conference Day Two Agenda:  HCV
 
Time Session
8:30-9:30 Breakfast
9:30-9:40 Opening Remarks and Housekeeping Items
9:40-11:45 Session One:  Future of HCV  Treatment
9:45-10:15 New Treatment Diagnostics and Technologies
10:15-10:45 Treatment Access & Prisons
10:45-10:55 Break
10:55-11:30 Community Mobilization
11:30-11:45 Q&A
11:45-12:45 Lunch
12:45-3:30 Session Two:  Eliminating Barriers to HCV Treatment Access
12:50-1:15 Aboriginal HCV Access
1:15-1:30 Newcomers and HCV Tx Access
1:30-1:45 Q&A
1:45-1:55 Break
1:55-3:15 Panel Discussion:  Pricing and Access Inequities
3:15-3:30 Wrap-up & Day Two Evaluations

UNTIL THE EVENT

Site Driven By